Search results
Results From The WOW.Com Content Network
WuXi PharmaTech was founded in December 2000 in Shanghai by organic chemist Ge Li. [1] [2]The company opened chemistry facilities in Tianjin in 2007. In 2008, WuXi PharmaTech acquired AppTec Laboratory Services Inc., a US-based company founded in 2001 with expertise in medical-device and biologics testing and with facilities in St. Paul, MN; Philadelphia, PA; and Atlanta, GA.
In 2023, Wuxi Biologics earned about 47% of its 17 billion yuan ($2.35 billion) in annual sales from North America and about 18% from China, according to its annual report.
September 10, 2024 at 1:13 AM. By Karen Freifeld. (Reuters) -The U.S. House of Representatives passed a bill on Monday that aims to restrict business with China's WuXi AppTec, BGI and several ...
March 7, 2024 at 1:29 AM. By Karen Freifeld and Michael Erman. (Reuters) -The U.S. Senate's homeland security committee voted on Wednesday to approve a bill that could restrict business with ...
In 2022, the WuXi STA Changzhou production campus initiated oligonucleotide and peptide manufacturing to expand cell and gene therapy advancements. [5] Additionally, the different WuXi AppTec entities are inaccurate in the article. See this source to explain the rename and the correct entities under the WuXi AppTec umbrella. As far as I ...
Inspired by the visit, Li quit the company and co-founded WuXi AppTec with his wife, Ning Zhao, [8] in Shanghai in 2000. [9] The company was listed in New York Stock Exchange before going public in Hong Kong in 2018. [10] [11] In 2011, Li was named a member of the Committee of One Hundred. [12]
June 6, 2024 at 6:36 AM. By Kirsty Needham and Andrew Silver. SYDNEY/SHANGHAI (Reuters) - Employees of drugmaker WuXi AppTec, under U.S. scrutiny for its links to the Chinese military, co-invented ...
Abgent is a global biotechnology company based in San Diego, California, US with offices in Maidenhead, UK and Suzhou, China and distributors around the world. Abgent develops antibodies and related agents to study proteins involved in cellular function and disease. Abgent's antibodies target key areas of research including autophagy ...